Bdparp Olaparib 150mg Tablet

150mg Tablet , Box

4.5 (154)

9,000

Olaparib 150mg Tablet contains Olaparib, a PARP inhibitor used to treat certain BRCA-mutated cancers. It is primarily prescribed for advanced ovarian, fallopian tube, primary peritoneal, and certain breast cancers after prior chemotherapy. The medicine works by blocking PARP enzymes, preventing cancer cells from repairing damaged DNA and leading to their destruction. Common side effects include fatigue, anemia, decreased appetite, nausea, and respiratory tract infections. Bdparp should only be taken under medical supervision, with regular monitoring throughout the treatment period.

Description

Introduction Of Olaparib 150mg Tablet:

Olaparib 150mg Tablet is a medication that belongs to a class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors. It is primarily used to treat certain types of cancer. Bdparp is available in different strengths, including the 150mg formulation.

This Tablet 150mg is primarily used for the treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is specifically indicated for patients who have a mutation in either the BRCA1 or BRCA2 genes and have previously received multiple lines of chemotherapy.

Side Effects Of Olaparib 150mg Tablet:

Like any medication, Olaparib 150mg Tablet may cause side effects. Common side effects include:

  • Fatigue
  • Anemia (low red blood cell count)
  • Decreased appetite
  • Respiratory tract infections

Not everyone experiences these side effects, and their severity can vary from person to person. If you are prescribed Bdparp 150mg, your healthcare provider will monitor your condition and help manage any side effects that may occur.

It is important to consult a healthcare professional for accurate and up-to-date information regarding the uses, dosage, and potential side effects of Bdparp 150mg, as individual circumstances may vary.

Mechanism Of Action Olaparib 150mg Tablet:

The mechanism of action of Olaparib 150mg Tablet involves inhibiting the activity of PARP enzymes. PARP enzymes play a role in repairing damaged DNA in cells. By inhibiting PARP, Bdparp 150mg (Olaparib) prevents the repair of damaged DNA in cancer cells, leading to their death. This mechanism is particularly effective in cancers that have deficiencies in DNA repair, such as those with mutations in the BRCA genes

Medicine Form Tablets
Medicine Name BDPARP 150mg
Medicine Strength 150mg
Packaging Size 56 Tablets

Contact Us

Info Table
Dose/Strength 150 mg
Brand Bdparp
Usage/Application Hospital
Drug Name Olaparib
Packaging Type Bottle
Packaging Size 56 Tablet per Box
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of Olaparib 150mg Tablet:

Olaparib 150mg Tablet is a medication that belongs to a class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors. It is primarily used to treat certain types of cancer. Bdparp is available in different strengths, including the 150mg formulation.

This Tablet 150mg is primarily used for the treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is specifically indicated for patients who have a mutation in either the BRCA1 or BRCA2 genes and have previously received multiple lines of chemotherapy.

Side Effects Of Olaparib 150mg Tablet:

Like any medication, Olaparib 150mg Tablet may cause side effects. Common side effects include:

  • Fatigue
  • Anemia (low red blood cell count)
  • Decreased appetite
  • Respiratory tract infections

Not everyone experiences these side effects, and their severity can vary from person to person. If you are prescribed Bdparp 150mg, your healthcare provider will monitor your condition and help manage any side effects that may occur.

It is important to consult a healthcare professional for accurate and up-to-date information regarding the uses, dosage, and potential side effects of Bdparp 150mg, as individual circumstances may vary.

Mechanism Of Action Olaparib 150mg Tablet:

The mechanism of action of Olaparib 150mg Tablet involves inhibiting the activity of PARP enzymes. PARP enzymes play a role in repairing damaged DNA in cells. By inhibiting PARP, Bdparp 150mg (Olaparib) prevents the repair of damaged DNA in cancer cells, leading to their death. This mechanism is particularly effective in cancers that have deficiencies in DNA repair, such as those with mutations in the BRCA genes

Medicine Form Tablets
Medicine Name BDPARP 150mg
Medicine Strength 150mg
Packaging Size 56 Tablets

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Bdparp Olaparib 150mg Tablet”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Olaparib 150mg Tablet used for?
It is used to treat advanced ovarian, fallopian tube, and primary peritoneal cancers, as well as certain BRCA-mutated breast cancers after prior chemotherapy.
It inhibits PARP enzymes, preventing cancer cells from repairing damaged DNA and leading to their destruction. For more details, refer to MedlinePlus Drug Information.
It is specifically indicated for patients with a mutation in the BRCA1 or BRCA2 genes who have previously received multiple lines of chemotherapy.
Common side effects include fatigue, anemia, decreased appetite, nausea, and respiratory tract infections.
It contains Olaparib 150mg, sold under the brand name Bdparp, packaged as 56 tablets per box.
Yes, it should only be taken under medical supervision, with regular monitoring throughout treatment.

Related products